Home | Health | Infectious Diseases
An antibiotic clindamycin phosphate glucose injection has been blamed for the deaths of three patients in China, says the Adverse Drug Reaction Monitoring Center of China's SFDA (State Food and Drug Administration). The agency has also received at least 80 reports of severe adverse reactions from ten provinces. The drug is produced by Anhui Huayuan Worldbest Biology Pharmacy Company, Anhui, China. The SFDA has banned the use of the injection and ordered all stocks to be withdrawn. Side effects include severe stomach pains, chronic nausea, vomiting, pain in the chest area and kidney pains. All cases are from people who received the injection after July 27. Authorities are searching for all batches relating to that date. Although authorities cannot confirm that the injection caused the deaths and illnesses yet, all the cases had received the antibiotic injection on or since July 27. Most health experts in China believe further tests will confirm the link. Written by: Christian Nordqvist Editor: Medical News Today
Article Source: http://www.new.citynewslive.com
Please Rate this Article
5 out of 54 out of 53 out of 52 out of 51 out of 5
Not yet Rated
